What Are Nucleases and What Are Their Functions?

Nucleases are enzymes that cut the chemical bonds holding nucleic acids together, breaking DNA or RNA into smaller pieces. Every living cell depends on them, from bacteria defending against viral invaders to human cells proofreading freshly copied DNA. Far from being simple molecular scissors, nucleases form one of the largest and most diverse enzyme families in biology, with over 100,000 proteins identified in one superfamily alone.¹ Their functions touch nearly every aspect of cellular life, and understanding them has reshaped both medicine and biotechnology.

How Nucleases Cut

The basic job of a nuclease is to break phosphodiester bonds, the links that chain individual nucleotides into strands of DNA or RNA. Most nucleases rely on metal ions to do this work. The best-understood mechanism involves two metal ions, typically magnesium, working in concert: one activates a water molecule to attack the bond, while the other stabilizes the fragment that gets released.² Studies on bacterial ribonuclease III, for instance, confirmed that two magnesium ions participate in cutting RNA.³

That two-metal model is widely accepted, but the real picture is messier. Some nucleases appear to function with only a single metal ion, a finding that remains debated among researchers.² And not all nucleases use metals at all. Metal-independent nucleases that target RNA generate a distinctive cyclic product when they cut, while metal-independent DNases work through an entirely different strategy, forming a temporary bond between the enzyme and the DNA.⁴ The diversity in cutting chemistry reflects how many different evolutionary paths have converged on the same basic task.

Endonucleases Versus Exonucleases

The broadest way to sort nucleases is by where they cut. Endonucleases cut in the middle of a nucleic acid strand, like snipping a rope at an interior point. Exonucleases chew from the ends, removing one nucleotide at a time. Some enzymes can actually do both, though specific amino acid residues within the protein determine which activity dominates. Research on E. coli’s ExoIII enzyme showed that a single aromatic residue at position 213 is essential for exonuclease activity; mutants retaining only the residue at position 212 kept their ability to cut at internal damaged sites but lost the ability to digest from the ends.⁵

Another layer of classification comes from substrate preference. DNases target DNA, RNases target RNA, and some nucleases are picky about the specific sequences or structures they recognize. Ribonuclease T1, for example, recognizes guanosine in RNA partly through a direct interaction between the sugar’s 2′-hydroxyl group and specific residues in the enzyme’s active site.⁶ That level of specificity matters because it prevents the enzyme from accidentally degrading the wrong molecule. Metal-dependent enzymes that cut DNA or RNA in its helical form tend to be associated with exonuclease activity producing single-nucleotide products, whereas some endonucleases target more complex, branched, or unusual structures.⁴

Proofreading During DNA Replication

Every time a cell divides, it must copy its entire genome. DNA polymerases handle the copying, but they are not perfect. When the wrong nucleotide gets inserted, many replicative polymerases have a built-in exonuclease that acts as a spell-checker. This exonuclease reads backward (3′ to 5′), snipping off the incorrect base so the polymerase can try again.⁷

The process is remarkably efficient. Studies of T7 DNA polymerase showed that the DNA strand physically transfers from the polymerase active site to the exonuclease active site and back again after the mismatch is removed, improving replication accuracy by more than a thousandfold.⁸ Human mitochondrial DNA polymerase uses a similar intramolecular shuttle: the strand transfers from one site to the other within the same enzyme complex, and the rate of excising mismatched bases speeds up as the number of mismatches increases, reaching a much faster pace than the excision of correctly paired DNA.⁹ The cost of this proofreading, measured as the rate at which correctly paired bases are needlessly removed, is tiny relative to the normal speed of copying.

Repairing Damaged DNA

DNA damage is constant. Ultraviolet light, reactive oxygen species, and even normal metabolic byproducts create lesions that must be fixed or the cell risks mutations and death. Nucleases are central to several repair pathways, each handling a different type of damage.

In nucleotide excision repair, the cell detects bulky distortions in the double helix, such as those caused by UV light. Two structure-specific endonucleases then make cuts on either side of the damage: ERCC1-XPF cuts on the 5′ side and XPG cuts on the 3′ side, releasing a short stretch of damaged DNA that gets replaced with a freshly synthesized patch.¹⁰ The equivalent proteins in fission yeast, Rad13 and Rad2, carry out similar incisions, with evidence that Rad13 may also contribute to base excision repair, another pathway that handles smaller lesions.¹¹

Double-strand breaks, where both strands of the helix are severed, represent a particularly dangerous form of damage. The MRE11 nuclease, part of the MRN complex, plays a pivotal role in deciding how these breaks get repaired. MRE11 has both endonuclease and exonuclease activities, and each steers the cell toward a different repair strategy. Its endonuclease activity initiates resection of the broken ends, licensing the cell to use homologous recombination, a high-fidelity repair method. The exonuclease activity then extends that resection, committing the cell to completing the job. When endonuclease activity is blocked, the cell shifts instead toward nonhomologous end-joining, a faster but more error-prone fix.¹² Additional proteins, including the Sae2/CtIP nuclease, cooperate with MRE11 to regulate both short-range and long-range resection at break sites.¹³

Base excision repair handles subtler damage, like oxidized or deaminated bases. Here, AP nucleases (named for their ability to recognize abasic, or “AP,” sites where a damaged base has been removed) cut the DNA backbone so the gap can be filled. Research in myeloma cells showed that knocking down the AP nucleases APE1 and APE2 together sharply reduced the activation of a separate repair pathway, homologous recombination, after exposure to DNA-damaging agents. In cells where both enzymes were depleted, the fraction showing signs of recombination-based repair dropped to roughly a quarter of normal levels after UV treatment.¹⁴ This cross-talk between repair pathways shows that nucleases do not just carry out mechanical cuts; they send signals that shape the broader damage response.

Managing RNA

Cells produce vast quantities of RNA, and much of it needs to be trimmed, processed, or broken down when its job is done. The RNA exosome is one of the most important nuclease complexes in this process. Conserved across virtually all eukaryotes, the exosome degrades defective or surplus RNA and trims precursor RNAs into their mature, functional forms.¹⁵

One well-studied exosome component, the exonuclease Rrp6p, works alongside other subunits to produce the mature 3′ ends of ribosomal RNA, small nucleolar RNAs, and small nuclear RNAs. It also destroys improperly processed precursor molecules that could otherwise accumulate and interfere with normal cell function.¹⁶ In trypanosomes, mRNA degradation typically begins with deadenylation (removal of the poly-A tail), after which the exosome degrades the remaining transcript from the 3′ end. Depleting a core exosome component in these organisms preferentially stabilized mRNAs with intermediate half-lives, suggesting that the exosome is especially active on messages whose lifespans the cell needs to tightly control.¹⁷

Triggering Programmed Cell Death

When a cell receives the signal to self-destruct during apoptosis, nucleases execute one of the final visible steps: shredding the cell’s own genome. The key player here is caspase-activated DNase (CAD). Under normal conditions, CAD is kept inactive by its inhibitor, ICAD. During apoptosis, the protease caspase-3 cleaves ICAD, releasing CAD to fragment chromosomal DNA.¹⁸ This fragmentation is what produces the characteristic DNA “laddering” that researchers use to confirm apoptosis in the lab.

More recently, though, researchers have found that CAD is not limited to full-blown cell suicide. In a process sometimes called subapoptotic caspase signaling, limited, controlled cleavage of ICAD releases just enough CAD activity to create DNA breaks without killing the cell. These breaks trigger a DNA damage response and activate signaling pathways that can redirect the cell’s fate, pushing it toward differentiation or other changes rather than death.¹⁹ It is a striking example of how the same enzyme can serve dramatically different purposes depending on context.

Bacterial Defense Against Viruses

Bacteria have been fighting viruses (bacteriophages) for billions of years, and nucleases are their primary weapons. The oldest known defense system is restriction-modification, in which a restriction endonuclease recognizes specific short DNA sequences and cuts any foreign DNA carrying those sequences. The bacterium protects its own DNA by chemically modifying the same sequences with a methyltransferase, creating a self-versus-nonself distinction.²⁰ These restriction enzymes became some of the first molecular biology tools. The first experiments demonstrating their utility were reported in 1971, and they quickly became foundational to the field.²¹

CRISPR-Cas systems represent a more sophisticated, adaptive form of immunity. In these systems, nucleases like Cas9 use small RNA guides to find and cut foreign DNA that matches sequences stored from previous infections. Intriguingly, restriction enzymes and CRISPR-Cas systems can cooperate. When restriction endonucleases cut invading phage DNA, the fragments generated can be captured by the CRISPR machinery as new “spacer” sequences, boosting the immune memory for future encounters. This means restriction provides a rapid first-line defense, while CRISPR builds a longer-lasting, targeted response from the debris.²²

The evolutionary roots of CRISPR-Cas nucleases run deep. IscB, an ancient nuclease guided by a small RNA called ωRNA, shares architectural and mechanistic features with Cas9, suggesting that today’s genome-editing workhorse descended from a much older family of RNA-guided DNA cutters.²³

When Nucleases Go Wrong

Because nucleases are involved in so many housekeeping tasks, defects in these enzymes can have serious consequences. One well-documented example involves DNASE1L3, a nuclease responsible for clearing cell-free DNA released during apoptosis and from neutrophil extracellular traps. When DNASE1L3 is deficient, either through inherited mutations or through autoantibodies that neutralize the enzyme, undigested DNA accumulates outside cells. This debris can trigger an immune reaction against the body’s own genetic material, contributing to systemic lupus erythematosus.²⁴ DNase1, a related enzyme, has been implicated in the same disease since the 1950s, and its importance has only grown as researchers have recognized that defective clearance of apoptotic debris is a driver of the autoimmune response in lupus.²⁵

Defects in the RNA exosome also cause disease. Because the exosome is essential for processing and degrading many types of RNA, mutations in its subunits have been linked to a range of conditions affecting tissues that depend heavily on precise RNA regulation, including certain neurological disorders.¹⁵ These examples underscore a theme: nucleases are not just destructive. Their absence or malfunction causes damage precisely because their controlled activity is what keeps the molecular machinery tidy.

Nucleases as Biotechnology Tools

The leap from understanding nucleases in nature to deploying them in the lab has produced some of the most transformative technologies in modern biology. Restriction enzymes launched the recombinant DNA revolution in the 1970s, but the more recent wave of programmable nucleases has dramatically expanded what is possible. Zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) are chimeric proteins that pair a customizable DNA-binding domain with a nonspecific nuclease domain, allowing researchers to create targeted double-strand breaks at chosen locations in a genome. Those breaks then get repaired by the cell’s own machinery, either introducing small mutations or, if a template is provided, writing in a precise edit.²⁶

CRISPR-Cas9 simplified this approach by replacing the protein-based DNA-binding domain with a short RNA guide, making it faster and cheaper to reprogram the nuclease for new targets. Beyond editing, CRISPR-derived nucleases now power diagnostic platforms. SHERLOCK, which uses the Cas13 nuclease, can detect specific DNA or RNA sequences with high sensitivity. In one application, researchers used SHERLOCK to quantify a glyphosate-resistance gene in soybean mixtures and detect multiple plant genes simultaneously. The assay runs in about fifteen minutes, works on crude plant extracts, and produces a color readout on a paper strip, making it field-deployable for agricultural testing.²⁷

Making Nucleases in the Lab

Harnessing nucleases for industrial and research use is not always straightforward. Producing them in large quantities through bacterial expression systems often runs into problems: the proteins can misfold, aggregate into insoluble clumps, or kill the host cells by digesting their DNA or RNA. Several strategies have been developed to work around this. Refolding misfolded proteins from inclusion bodies, carefully controlling when and where the nuclease is produced within the cell, and co-expressing the nuclease alongside its natural inhibitor protein have all been shown to increase yield and preserve biological activity.²⁸ The inhibitor trick is especially elegant: it is essentially the same principle cells use to keep nucleases like CAD in check, borrowed and applied to a fermentation tank.

The practical challenges of nuclease production also hint at something deeper about how cells handle these enzymes in nature. A nuclease floating freely inside a cell is a loaded weapon. Compartmentalization, inhibitor proteins, post-translational modifications, and tight transcriptional control all serve to keep nuclease activity aimed at the right targets. When those safeguards fail, the result can be anything from genomic instability to autoimmune disease, as the lupus example illustrates. The same properties that make nucleases so useful, their ability to slice through nucleic acids with precision or brute force, make them dangerous when uncontrolled. Evolution has spent billions of years solving that problem in a hundred different ways, and biotechnologists are still catching up.